A combination of Avastin with another drug is showing promise in fighting brain cancer.
Researchers at the Mayo Clinic found that pairing Avastin with a second drug called Dasatinib stopped the spread of tumors in a small group of patients.
A larger trial is underway.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.